Related references
Note: Only part of the references are listed.Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Emmanouil Fokas et al.
JAMA ONCOLOGY (2022)
Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial
Xiangbing Deng et al.
BRITISH JOURNAL OF SURGERY (2022)
Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial
Aurelie Garant et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials
E. F. Giunta et al.
CANCER TREATMENT REVIEWS (2021)
The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial
Jingwen Wang et al.
CLINICAL COLORECTAL CANCER (2020)
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer
Ji Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With Good Prognosis Rectal Cancer Eligible for Primary Surgery The Phase 2 Nonrandomized QuickSilver Clinical Trial
Erin D. Kennedy et al.
JAMA ONCOLOGY (2019)
Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer
Jianwei Zhang et al.
CLINICAL COLORECTAL CANCER (2019)
Impact of Long-Course Neoadjuvant Radiation on Postoperative Low Anterior Resection Syndrome and Quality of Life in Rectal Cancer: Post Hoc Analysis of a Randomized Controlled Trial
Weipeng Sun et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial
Akihiro Tomida et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 28, pg 22, 2017)
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2018)
Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial
R. Ruppert et al.
BRITISH JOURNAL OF SURGERY (2018)
Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy
Taihei Oshiro et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
E. Akgun et al.
BRITISH JOURNAL OF SURGERY (2018)
Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
Junichi Nishimura et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
The Microbiome and Radiation Induced-Bowel Injury: Evidence for Potential Mechanistic Role in Disease Pathogenesis
Tomoko Kumagai et al.
NUTRIENTS (2018)
Prospective randomized trial of neoadjuvant chemotherapy during the 'wait period' following preoperative chemoradiotherapy for rectal cancer: results of the WAIT trial
J. Moore et al.
COLORECTAL DISEASE (2017)
Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
K. Bujko et al.
ANNALS OF ONCOLOGY (2016)
Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer
S. Gollins et al.
CLINICAL ONCOLOGY (2016)
Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study
T. Kamiya et al.
EJSO (2016)
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Yi Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Neoadjuvant Radiotherapy for Rectal Cancer: Meta-analysis of Randomized Controlled Trials
Nuh N. Rahbari et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Share Paper
